Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Other financing activities (2016 - 2025)

Apyx Medical (APYX) has disclosed Other financing activities for 10 consecutive years, with -$60000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other financing activities changed N/A year-over-year to -$60000.0, compared with a TTM value of $60000.0 through Sep 2025, changed N/A, and an annual FY2023 reading of $147000.0, changed N/A over the prior year.
  • Other financing activities was -$60000.0 for Q4 2025 at Apyx Medical, down from $30000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $1.8 million in Q1 2023 and bottomed at -$1.6 million in Q3 2023.